Clinical trial

Insulin Resistance Following ADT for Prostate CA

NCT04658849

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2020-12-02

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2020-12-02Date precision: day

Registry last updated2023-05-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Insulin Resistanceunresolved

Prostate Cancerunresolved

Interventions

Pioglitazone 30 Mg Oral TabletDRUG · verified · RxNorm: pioglitazone 30 MG Oral Tablet

Pioglitazone placebo tabletDRUG

Sponsors & collaborators

St. Louis Universitylead sponsor

Mapped research locations

St LouisMissouri, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04658849 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.